Johnson & Johnson Innovation will host a virtual partnering event to actively engage with the German & DACH life sciences ecosystem and highlight how we interact with entrepreneurs, universities, startups and other innovators.
This will be relevant for innovators across all our therapeutic areas (Oncology, Immunology, Infectious Diseases & Vaccines, Cardio Vascular/Metabolic, Neuroscience), as well as for Medical Devices and Consumer Healthcare. For more information on the areas of strategic interest check the event page.
Companies can apply to get the opportunity for 1:1 meetings with the J&J Innovation cross-sectoral team by submitting a request before October 20, 2020.
November 17, 10:30-12:00 CET: The Johnson & Johnson Innovation Model: Innovation Through Collaboration
A briefing on our goals and mission, highlighting how we interact with the entrepreneurial community through incubation (JLABS), investment (JJDC), early stage partnerships and deals (Innovation Centers), and late stage deals (Business Development).
November 17-18: Virtual Partnering Meetings
Companies/researchers/organizations that are based in Germany and interested in talking to the team in 1:1 virtual meeting need to apply by 20 October EOD CET by submitting their non-confidential information. Successful applicants will be invited to virtual 1:1 meetings with the Johnson & Johnson Innovation team on 17-18 November.